Literature DB >> 23537547

EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot).

Aldo P Maggioni1, Ulf Dahlström, Gerasimos Filippatos, Ovidiu Chioncel, Marisa Crespo Leiro, Jaroslaw Drozdz, Friedrich Fruhwald, Lars Gullestad, Damien Logeart, Gianna Fabbri, Renato Urso, Marco Metra, John Parissis, Hans Persson, Piotr Ponikowski, Mathias Rauchhaus, Adriaan A Voors, Olav Wendelboe Nielsen, Faiez Zannad, Luigi Tavazzi.   

Abstract

AIMS: The ESC-HF Pilot survey was aimed to describe clinical epidemiology and 1-year outcomes of outpatients and inpatients with heart failure (HF). The pilot phase was also specifically aimed at validating structure, performance, and quality of the data set for continuing the survey into a permanent Registry.
METHODS: The ESC-HF Pilot study is a prospective, multicentre, observational survey conducted in 136 Cardiology Centres in 12 European countries selected to represent the different health systems across Europe. All outpatients with HF and patients admitted for acute HF on 1 day per week for eight consecutive months were included. From October 2009 to May 2010, 5118 patients were included: 1892 (37%) admitted for acute HF and 3226 (63%) patients with chronic HF. The all-cause mortality rate at 1 year was 17.4% in acute HF and 7.2% in chronic stable HF. One-year hospitalization rates were 43.9% and 31.9%, respectively, in hospitalized acute and chronic HF patients. Major regional differences in 1-year mortality were observed that could be explained by differences in characteristics and treatment of the patients.
CONCLUSION: The ESC-HF Pilot survey confirmed that acute HF is still associated with a very poor medium-term prognosis, while the widespread adoption of evidence-based treatments in patients with chronic HF seems to have improved their outcome profile. Differences across countries may be due to different local medical practice as well to differences in healthcare systems. This pilot study also offered the opportunity to refine the organizational structure for a long-term extended European network.

Entities:  

Keywords:  Acute heart failure; Chronic heart failure; Observational studies; Pharmacological treatments; Prognosis

Mesh:

Substances:

Year:  2013        PMID: 23537547     DOI: 10.1093/eurjhf/hft050

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  183 in total

1.  Significance of congestive heart failure as a cause of pleural effusion: Pilot data from a large multidisciplinary teaching hospital.

Authors:  Piotr Korczyński; Katarzyna Górska; Damian Konopka; Dżamila Al-Haj; Krzysztof J Filipiak; Rafał Krenke
Journal:  Cardiol J       Date:  2018-11-08       Impact factor: 2.737

2.  Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.

Authors:  Stephen J Greene; Ami N Shah; Javed Butler; Andrew P Ambrosy; Stefan D Anker; Ovidiu Chioncel; Sean P Collins; Wilfried Dinh; Preston M Dunnmon; Gregg C Fonarow; Carolyn S P Lam; Robert J Mentz; Burkert Pieske; Lothar Roessig; Giuseppe M C Rosano; Naoki Sato; Muthiah Vaduganathan; Mihai Gheorghiade
Journal:  Am Heart J       Date:  2014-05-24       Impact factor: 4.749

3.  How to Improve Adherence to Life-saving Heart Failure Treatments with Potassium Binders.

Authors:  Mitja Lainscak
Journal:  Card Fail Rev       Date:  2017-04

Review 4.  Turning Failure into Success: Trials of the Heart Failure Clinical Research Network.

Authors:  Emer Joyce; Michael M Givertz
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

Review 5.  Creation of a restrictive atrial left-to-right shunt: a novel treatment for heart failure.

Authors:  R De Rosa; D Schranz
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

Review 6.  Therapeutic Advances in the Management of Acute Decompensated Heart Failure.

Authors:  Elena-Laura Antohi; Andrew P Ambrosy; Sean P Collins; Ali Ahmed; Vlad Anton Iliescu; Gad Cotter; Peter S Pang; Javed Butler; Ovidiu Chioncel
Journal:  Am J Ther       Date:  2019 Mar/Apr       Impact factor: 2.688

Review 7.  Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes.

Authors:  Andrew P Ambrosy; Mihai Gheorghiade; Ovidiu Chioncel; Robert J Mentz; Javed Butler
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 8.  Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin.

Authors:  Roland E Schmieder; Veselin Mitrovic; Christian Hengstenberg
Journal:  Clin Res Cardiol       Date:  2015-03-19       Impact factor: 5.460

Review 9.  Addressing the Heterogeneity of Heart Failure in Future Randomized Trials.

Authors:  Annamaria Iorio; Andrea Pozzi; Michele Senni
Journal:  Curr Heart Fail Rep       Date:  2017-06

10.  Plasma galectin 3 and heart failure risk in the Physicians' Health Study.

Authors:  Luc Djoussé; Chisa Matsumoto; Andrew Petrone; Natalie L Weir; Michael Y Tsai; J Michael Gaziano
Journal:  Eur J Heart Fail       Date:  2013-12-04       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.